Acciones HedgePath Pharmaceuticals Inc
Acciones
US42278K1025
Biotecnología e investigación médica
Directores | Puesto | Edad | Desde |
---|---|---|---|
Frank O'Donnell
CEO | Chief Executive Officer | 74 | 13/12/22 |
James McNulty
DFI | Director of Finance/CFO | 73 | 13/12/22 |
Amy M. McCord
LAW | General Counsel | - | 01/01/19 |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Frank O'Donnell
CEO | Chief Executive Officer | 74 | 13/12/22 |
Samuel Sears
BRD | Director/Board Member | 80 | 02/08/13 |
Ronald Osman
BRD | Director/Board Member | 78 | 23/08/23 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+29,03 % | 49,18 mil M | |
-0,10 % | 42,11 mil M | |
+47,07 % | 40,37 mil M | |
-5,26 % | 28,85 mil M | |
+11,48 % | 26,09 mil M | |
-22,74 % | 18,71 mil M | |
+9,06 % | 13,26 mil M | |
+30,01 % | 12,32 mil M | |
-1,51 % | 11,99 mil M |